Piowin G 2mg/500mg/15mg Tablet SR
Marketer
Serwina Pharmaceuticals Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Piowin G 2mg/500mg/15mg Tablet SR
Glyburide-metformin-pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination medication managing blood glucose. This treatment, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It promotes efficient insulin use, reducing blood sugar. Dosage and duration for Glyburide-metformin-pioglitazone should strictly follow your physician's instructions. Take it with food to prevent digestive discomfort. If a dose is missed, take it immediately unless the next dose is imminent; then, omit the missed dose and resume your usual schedule. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals raises hypoglycemia risk. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before starting this medication, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals must consult their doctor. Kidney function tests will be performed before treatment commences. Limit alcohol consumption, as it may heighten side effect risks.
Uses of Piowin G 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Piowin G 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Piowin G 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Piowin G 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Piowin G 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Piowin G 2mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with food.
How Piowin G 2mg/500mg/15mg Tablet SR works:
Piowin G SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Piowin G 2mg/500mg/15mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Piowin G 2mg/500mg/15mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Piowin G 2mg/500mg/15mg tablet is likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Piowin G 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Piowin G 2mg/500mg/15mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.
LiverCAUTION
Patients with liver impairment should use Piowin G 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of Piowin G 2mg/500mg/15mg SR tablets is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Piowin G 2mg/500mg/15mg Tablet SR :
Should you forget to take a Piowin G 2mg/500mg/15mg Tablet SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Piowin G 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently